Oracle holder plans $1.5M stock sale

ORACLE CORP (ORCL) is the issuer for a planned Rule 144 sale by Michael D. Sicilia, involving 10,882 shares of common stock.

Rhea-AI Filing Summary

ORACLE CORP (ORCL) is the issuer for a planned Rule 144 sale by Michael D. Sicilia, involving 10,882 shares of common stock. The shares relate to restricted stock vesting on September 15, 2026, with the sale to be handled through Fidelity Brokerage Services LLC on the NYSE. The aggregate market value of the shares listed for potential sale is $1,522,827.08, and the filing notes that 3,023,736,000 shares of this class were outstanding as of September 16, 2026.

Key Figures

Shares to be sold: 10,882 shares Aggregate market value: $1,522,827.08 Shares outstanding: 3,023,736,000 shares +2 more

5 metrics

Shares to be sold 10,882 shares Oracle common stock covered by the Rule 144 notice

Aggregate market value $1,522,827.08 Value of 10,882 Oracle common shares listed in the Form 144

Shares outstanding 3,023,736,000 shares Oracle common shares outstanding as of September 16, 2026

Vesting date September 15, 2026 Restricted stock vesting tied to the shares to be sold

Planned sale date context September 16, 2026 Date associated with the sale information and outstanding shares

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 09/15/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ORCL disclose?

It discloses a planned Rule 144 sale by Michael D. Sicilia for 10,882 shares of Oracle common stock, arising from restricted stock vesting on September 15, 2026, to be sold through Fidelity Brokerage Services LLC on the NYSE.

How many Oracle (ORCL) shares are covered by this Rule 144 notice?

The notice covers 10,882 shares of Oracle common stock, with an indicated aggregate market value of $1,522,827.08 at the time of the filing.

What is the aggregate market value of the ORCL shares in this Form 144?

The aggregate market value of the 10,882 shares of Oracle common stock listed in the Form 144 is $1,522,827.08, based on the figures provided in the filing.

How many Oracle (ORCL) common shares were outstanding according to this Form 144?

The filing states that there were 3,023,736,000 shares of Oracle common stock outstanding as of September 16, 2026, which is presented as contextual information alongside the planned sale.

What is the source of the Oracle (ORCL) shares in this Rule 144 filing?

The shares are tied to restricted stock vesting dated September 15, 2026, with the transaction described as related to compensation and the issuer identified as Oracle Corp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 09:36 AM Accepted by SEC EDGAR 09/16/2026 - 09:35 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002071965
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORACLE CORP
SEC File Number	001-35992
Address of Issuer	2300 ORACLE WAY AUSTIN TEXAS 78741
Phone	(737) 867-1000
Name of Person for Whose Account the Securities are To Be Sold	Sicilia Michael D.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10882	1522827.08	3023736000	09/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Restricted Stock Vesting	Issuer			10882	09/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Sicilia
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)